SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001213900-24-002342
Filing Date
2024-01-09
Accepted
2024-01-09 17:00:47
Documents
3

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea191405-8k425_10xcap3.htm 425 33577
2 JOINDER TO THE LETTER AGREEMENT, DATED JANUARY 9, 2024, BETWEEN 10X III, THE SPO ea191405ex10-1_10xcap3.htm EX-10.1 9302
3 PRESS RELEASE, DATED JANUARY 8, 2024 ea191405ex99-1_10xcap3.htm EX-99.1 11371
  Complete submission text file 0001213900-24-002342.txt   55940
Mailing Address 1 WORLD TRADE CENTER FLOOR 85 NEW YORK NY 10007
Business Address 1 WORLD TRADE CENTER FLOOR 85 NEW YORK NY 10007 (212) 257-0069
10X Capital Venture Acquisition Corp. III (Filed by) CIK: 0001848948 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 1 WORLD TRADE CENTER FLOOR 85 NEW YORK NY 10007
Business Address 1 WORLD TRADE CENTER FLOOR 85 NEW YORK NY 10007 (212) 257-0069
10X Capital Venture Acquisition Corp. III (Subject) CIK: 0001848948 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-41216 | Film No.: 24523963
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)